NCT05141682 2026-03-03Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic LeukemiaOhio State University Comprehensive Cancer CenterPhase 1/2 Active not recruiting11 enrolled